Stratum Biosciences focuses on leveraging artificial intelligence alongside biomarker discovery to create new dermatological therapies.
Stratum Biosciences has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in March 2026.
Stratum Biosciences's investors include Harvard Business School Alumni Angels of Greater NY, Skin Angels.
Stratum Biosciences is headquartered in New York, United States.
Stratum Biosciences focuses on leveraging artificial intelligence alongside biomarker discovery to create new dermatological therapies.
Stratum Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Stratum Biosciences — Funding & Investors." VCBacked, March 27, 2026, https://www.vcbacked.co/company/stratum-biosciences. Accessed September 14, 2026.
VCBacked. (2026). Stratum Biosciences — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/stratum-biosciences
{{cite web |title=Stratum Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/stratum-biosciences |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated